Literature DB >> 17041038

Characterization of the Moraxella catarrhalis opa-like protein, OlpA, reveals a phylogenetically conserved family of outer membrane proteins.

Michael J Brooks1, Cassie A Laurence, Eric J Hansen, Scott D Gray-Owen.   

Abstract

Moraxella catarrhalis is a human-restricted pathogen that can cause respiratory tract infections. In this study, we identified a previously uncharacterized 24-kDa outer membrane protein with a high degree of similarity to Neisseria Opa protein adhesins, with a predicted beta-barrel structure consisting of eight antiparallel beta-sheets with four surface-exposed loops. In striking contrast to the antigenically variable Opa proteins, the M. catarrhalis Opa-like protein (OlpA) is highly conserved and constitutively expressed, with 25 of 27 strains corresponding to a single variant. Protease treatment of intact bacteria and isolation of outer membrane vesicles confirm that the protein is surface exposed yet does not bind host cellular receptors recognized by neisserial Opa proteins. Genome-based analyses indicate that OlpA and Opa derive from a conserved family of proteins shared by a broad array of gram-negative bacteria.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17041038      PMCID: PMC1797210          DOI: 10.1128/JB.00788-06

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  35 in total

Review 1.  Bacterial infection in chronic obstructive pulmonary disease.

Authors:  T F Murphy; S Sethi
Journal:  Am Rev Respir Dis       Date:  1992-10

Review 2.  Type IV pilus structure and bacterial pathogenicity.

Authors:  Lisa Craig; Michael E Pique; John A Tainer
Journal:  Nat Rev Microbiol       Date:  2004-05       Impact factor: 60.633

3.  Multiple sequence alignment with hierarchical clustering.

Authors:  F Corpet
Journal:  Nucleic Acids Res       Date:  1988-11-25       Impact factor: 16.971

4.  A simple method for displaying the hydropathic character of a protein.

Authors:  J Kyte; R F Doolittle
Journal:  J Mol Biol       Date:  1982-05-05       Impact factor: 5.469

5.  Moraxella catarrhalis in chronic obstructive pulmonary disease: burden of disease and immune response.

Authors:  Timothy F Murphy; Aimee L Brauer; Brydon J B Grant; Sanjay Sethi
Journal:  Am J Respir Crit Care Med       Date:  2005-04-01       Impact factor: 21.405

6.  Isolation of the outer membrane of Branhamella catarrhalis.

Authors:  T F Murphy; M R Loeb
Journal:  Microb Pathog       Date:  1989-03       Impact factor: 3.738

Review 7.  Branhamella catarrhalis: epidemiology, surface antigenic structure, and immune response.

Authors:  T F Murphy
Journal:  Microbiol Rev       Date:  1996-06

8.  A major outer membrane protein of Moraxella catarrhalis is a target for antibodies that enhance pulmonary clearance of the pathogen in an animal model.

Authors:  M E Helminen; I Maciver; J L Latimer; L D Cope; G H McCracken; E J Hansen
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

9.  Immune response to outer membrane antigens of Moraxella catarrhalis in children with otitis media.

Authors:  H Faden; J Hong; T Murphy
Journal:  Infect Immun       Date:  1992-09       Impact factor: 3.441

10.  Binding of syndecan-like cell surface proteoglycan receptors is required for Neisseria gonorrhoeae entry into human mucosal cells.

Authors:  J P van Putten; S M Paul
Journal:  EMBO J       Date:  1995-05-15       Impact factor: 11.598

View more
  7 in total

Review 1.  Potential impact of a Moraxella catarrhalis vaccine in COPD.

Authors:  Antonia C Perez; Timothy F Murphy
Journal:  Vaccine       Date:  2017-02-06       Impact factor: 3.641

Review 2.  Panel 5: Microbiology and immunology panel.

Authors:  Timothy F Murphy; Tasnee Chonmaitree; Stephen Barenkamp; Jennelle Kyd; Johanna Nokso-Koivisto; Janak A Patel; Terho Heikkinen; Noboru Yamanaka; Pearay Ogra; W Edward Swords; Tania Sih; Melinda M Pettigrew
Journal:  Otolaryngol Head Neck Surg       Date:  2013-04       Impact factor: 3.497

3.  The modA10 phasevarion of nontypeable Haemophilus influenzae R2866 regulates multiple virulence-associated traits.

Authors:  Timothy M VanWagoner; John M Atack; Kevin L Nelson; Hannah K Smith; Kate L Fox; Michael P Jennings; Terrence L Stull; Arnold L Smith
Journal:  Microb Pathog       Date:  2015-12-21       Impact factor: 3.738

Review 4.  Panel 6: Vaccines.

Authors:  Stephen I Pelton; Melinda M Pettigrew; Stephen J Barenkamp; Fabrice Godfroid; Carlos G Grijalva; Amanda Leach; Janak Patel; Timothy F Murphy; Sanja Selak; Lauren O Bakaletz
Journal:  Otolaryngol Head Neck Surg       Date:  2013-04       Impact factor: 3.497

Review 5.  A Moraxella catarrhalis vaccine to protect against otitis media and exacerbations of COPD: An update on current progress and challenges.

Authors:  Antonia C Perez; Timothy F Murphy
Journal:  Hum Vaccin Immunother       Date:  2017-10-03       Impact factor: 3.452

Review 6.  Vaccine targets against Moraxella catarrhalis.

Authors:  Dabin Ren; Michael E Pichichero
Journal:  Expert Opin Ther Targets       Date:  2015-08-26       Impact factor: 6.902

7.  Comparative Genomic Analyses of the Moraxella catarrhalis Serosensitive and Seroresistant Lineages Demonstrate Their Independent Evolution.

Authors:  Joshua P Earl; Stefan P W de Vries; Azad Ahmed; Evan Powell; Matthew P Schultz; Peter W M Hermans; Darryl J Hill; Zhemin Zhou; Crystala I Constantinidou; Fen Z Hu; Hester J Bootsma; Garth D Ehrlich
Journal:  Genome Biol Evol       Date:  2016-04-06       Impact factor: 3.416

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.